Skip to main content
Erschienen in: Abdominal Radiology 10/2016

17.06.2016 | Perspective

Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology

verfasst von: Julien S. Wonderlick, Robert D’Agostino

Erschienen in: Abdominal Radiology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Clostridium difficile is a well-established cause of nosocomial gastrointestinal disease. Although antibiotics remain an effective first-line treatment for C. difficile colitis (CDC), relapse and recurrence are common. FMT has emerged as one of the safest and most effective known therapies available for recurrent or refractory CDC, which is likely due to restoration of the protective microbiotic barrier of the gastrointestinal tract. FMT varies greatly across institutions by route of delivery, dose, and protocol. We present our experience with FMT via fluoroscopic-guided nasojejunal catheter placement. The discussion will include indications and contraindications, protocol, and procedural technique, and include a case presentation incorporating original CT and fluoroscopic images. Specifically, we will address the advantages and disadvantages of image-guided FMT via the upper GI tract with respect to nasogastric-, colonoscopic-, and enema-based delivery. The efficacy of FMT for the treatment of C. difficile has been widely demonstrated in several prospective and case studies. We feel that nasojejunal FMT is an underutilized radiologic procedure which can benefit selected patients, particularly given the advantages in risk profile, cost, convenience, and lack of routine sedation.
Literatur
1.
Zurück zum Zitat Riddle DJ, Dubberke ER (2009) Trends in Clostridium difficile disease: epidemiology and intervention. Infect Med. 26(7):211–220 Riddle DJ, Dubberke ER (2009) Trends in Clostridium difficile disease: epidemiology and intervention. Infect Med. 26(7):211–220
2.
Zurück zum Zitat Barbut F, Richard A, Hamadi K, et al. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386–2388PubMedPubMedCentral Barbut F, Richard A, Hamadi K, et al. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386–2388PubMedPubMedCentral
3.
Zurück zum Zitat Loo VG, Bourgault AM, Poirier L, et al. (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365(18):1693–1703CrossRefPubMed Loo VG, Bourgault AM, Poirier L, et al. (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365(18):1693–1703CrossRefPubMed
4.
Zurück zum Zitat Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553CrossRefPubMedPubMedCentral Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat van Nood E, Vrieze A, Nieuwdorp M, et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415CrossRefPubMed van Nood E, Vrieze A, Nieuwdorp M, et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415CrossRefPubMed
7.
Zurück zum Zitat Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108(4):500–508CrossRefPubMed Kassam Z, Lee CH, Yuan Y, Hunt RH (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108(4):500–508CrossRefPubMed
8.
Zurück zum Zitat Drekonja D, Reich J, Gezahegn S, et al. (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162(9):630–638CrossRefPubMed Drekonja D, Reich J, Gezahegn S, et al. (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162(9):630–638CrossRefPubMed
9.
Zurück zum Zitat Costello SP, Chung A, Andrews JM, Fraser RJ (2015) Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol 110(5):775–777CrossRefPubMed Costello SP, Chung A, Andrews JM, Fraser RJ (2015) Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol 110(5):775–777CrossRefPubMed
10.
Zurück zum Zitat Seril DN, Ashburn JH, Lian L, Shen B (2014) Risk factors and management of refractory or recurrent Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis 20(12):2226–2233CrossRefPubMed Seril DN, Ashburn JH, Lian L, Shen B (2014) Risk factors and management of refractory or recurrent Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis 20(12):2226–2233CrossRefPubMed
11.
Zurück zum Zitat Moayyedi P, Surette MG, Kim PT, et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109CrossRefPubMed Moayyedi P, Surette MG, Kim PT, et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109CrossRefPubMed
Metadaten
Titel
Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology
verfasst von
Julien S. Wonderlick
Robert D’Agostino
Publikationsdatum
17.06.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 10/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0801-0

Weitere Artikel der Ausgabe 10/2016

Abdominal Radiology 10/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.